Literature DB >> 3290688

A yeast activity can substitute for the HeLa cell TATA box factor.

B Cavallini1, J Huet, J L Plassat, A Sentenac, J M Egly, P Chambon.   

Abstract

Most class B (II) promoter regions from higher eukaryotes contain the TATA box and upstream and enhancer elements. Both the upstream and enhancer elements and their cognate factors have regulatory functions, whereas the TATA sequence interacts with the TATA box factor BTF1 to position RNA polymerase B and its ancillary initiation factors (STF, BTF2 and BTF3) to direct the initiation of transcription approximately 30 base pairs downstream. In many respects, class B promoter regions from the unicellular eukaryote Saccharomyces cerevisiae are similarly organized, containing upstream activating sequences that bear many similarities to enhancers. Although they are essential for initiation, the yeast TATA sequences are located at variable distances and further from the start sites (40-120 base pairs), whose locations are primarily determined by an initiator element. The basic molecular mechanisms that control initiation of transcription are known to be conserved from yeast to man: the yeast transcriptional transactivator GAL4 can activate a minimal TATA box-containing promoter in human HeLa cells, and a human inducible enhancer factor, the oestrogen receptor, can activate a similar minimal promoter in yeast. This striking evolutionary conservation prompted us to look for the presence in yeast of an activity that could possibly substitute for the human TATA box factor. We report here the existence of such an activity in yeast extracts.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3290688     DOI: 10.1038/334077a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  91 in total

1.  hnRNP U inhibits carboxy-terminal domain phosphorylation by TFIIH and represses RNA polymerase II elongation.

Authors:  M K Kim; V M Nikodem
Journal:  Mol Cell Biol       Date:  1999-10       Impact factor: 4.272

2.  EFG1 null mutants of Candida albicans switch but cannot express the complete phenotype of white-phase budding cells.

Authors:  T Srikantha; L K Tsai; K Daniels; D R Soll
Journal:  J Bacteriol       Date:  2000-03       Impact factor: 3.490

3.  DNA sequences required for yeast actin gene transcription do not include conserved CCAAT motifs.

Authors:  J M Munholland; J K Kelly; A G Wildeman
Journal:  Nucleic Acids Res       Date:  1990-10-25       Impact factor: 16.971

4.  TFIIA induces conformational changes in TFIID via interactions with the basic repeat.

Authors:  D K Lee; J DeJong; S Hashimoto; M Horikoshi; R G Roeder
Journal:  Mol Cell Biol       Date:  1992-11       Impact factor: 4.272

5.  The TATA-binding protein participates in TFIIIB assembly on tRNA genes.

Authors:  J Huet; A Sentenac
Journal:  Nucleic Acids Res       Date:  1992-12-25       Impact factor: 16.971

6.  Complex requirements for RNA polymerase III transcription of the Xenopus U6 promoter.

Authors:  K A Simmen; I W Mattaj
Journal:  Nucleic Acids Res       Date:  1990-10-11       Impact factor: 16.971

7.  Heat shock-regulated transcription in vitro from a reconstituted chromatin template.

Authors:  P B Becker; S K Rabindran; C Wu
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-15       Impact factor: 11.205

8.  cDNA clone encoding Drosophila transcription factor TFIID.

Authors:  M L Muhich; C T Iida; M Horikoshi; R G Roeder; C S Parker
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

9.  Characterization of the transcriptional potency of sub-elements of the UAS of the yeast PGK gene in a PGK mini-promoter.

Authors:  C A Stanway; A Chambers; A J Kingsman; S M Kingsman
Journal:  Nucleic Acids Res       Date:  1989-11-25       Impact factor: 16.971

10.  Identification of a yeast protein with properties similar to those of the immunoglobulin heavy-chain enhancer-binding protein NF-muE3.

Authors:  H Beckmann; T Kadesch
Journal:  Mol Cell Biol       Date:  1989-10       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.